Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
about
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver diseaseHigh susceptibility to fatty liver disease in two-pore channel 2-deficient miceAcute accumulation of free cholesterol induces the degradation of perilipin 2 and Rab18-dependent fusion of ER and lipid droplets in cultured human hepatocytesHigh-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatmentER stress and hepatic lipid metabolism.E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Impaired liver function in Xenopus tropicalis exposed to benzo[a]pyrene: transcriptomic and metabolic evidenceRecent insights into farnesoid X receptor in non-alcoholic fatty liver disease.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Identification of genes whose expression is altered by obesity throughout the arterial tree.The influence of dietary fat on liver fat accumulation.Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsOntogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophagesHigh folic acid consumption leads to pseudo-MTHFR deficiency, altered lipid metabolism, and liver injury in mice.Lessons from hepatocyte-specific Cyp51 knockout mice: impaired cholesterol synthesis leads to oval cell-driven liver injury.LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages.Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolismMitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Complexity of microRNA function and the role of isomiRs in lipid homeostasis.PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.Systemic and renal lipids in kidney disease development and progression.Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in MiceEffects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approachOxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease.SULT2B1: unique properties and characteristics of a hydroxysteroid sulfotransferase family.Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis.Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease.Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
P2860
Q26798151-94932054-C732-40B9-BE00-8A521A1EFD74Q27007515-76E0EFF0-0AA8-4B16-AB26-583AFC4DCD5BQ27016052-5C6DD65A-5BD8-4418-82D0-70736B82FACBQ28246421-36B4CE9E-B775-442B-8D34-D12705E0E4C0Q30832471-D53CB00A-B5D2-44ED-A01E-C7244EE2074FQ33584533-89065B11-6D3A-45B2-AA8E-C992D197755CQ33607587-A71D913F-4029-4A81-9F8B-09D75AF6E21AQ33620277-A8927B3D-A0D9-4D3B-9F49-F7C2BA78BFD0Q33703222-EB061148-7B65-4808-B168-7045B5FD4E80Q33755566-39A90078-01ED-4533-AB5B-D9D621793DF9Q33755805-08DDCFB5-B2BB-41CD-BCB2-DB81CD0B5D95Q33958697-8BA0D696-5FE4-47B8-88F0-0C4CE1609872Q34076651-A9644D05-975E-42E2-99CD-CF8A401DD7F3Q34303001-7F42F826-40BA-488D-9F2A-2E014F876E4CQ34336370-8CB838D0-E8FE-4021-A851-44675DC8D479Q34519267-B7A4066A-3C1B-4F35-9251-4584B5B610E8Q34578071-E85C19FD-22B9-4794-93E1-29ADF05C3556Q34750585-19FE0CBB-818C-4016-A843-AA51E8D1B12DQ34800989-C80B4186-8611-422B-B8ED-8D380705DF70Q35000376-716108BC-F7F9-434E-BC5D-D7643130E777Q35120259-1D95545A-0374-4CFC-9609-4EAA8F7F6367Q35148751-154C9FC8-A83C-42AA-BA0B-9540A2BEA8A8Q35659751-F7D64837-3869-4BB8-A50A-4C073A3E8BD6Q36237764-FEB9FE5E-9ED2-4354-A0A7-807C10FD4B57Q36320944-28C5FB7A-7615-46B4-A910-253B0F3CC011Q36530010-0574670B-1FF3-4FDD-BF3B-82A4C8ECAAFEQ36720511-1158E209-2A50-47D6-97AD-0FC319CB9B65Q36740555-EF1F90F5-53AC-4C80-9E0B-B075C6A3B2C2Q36754775-CD3CCAF5-530D-4287-B154-549962823B0FQ36939099-F62D1A5B-924E-444B-9DAA-369283E5C3A1Q37148885-E4F34EB6-0636-4430-8019-E443797A5708Q37231732-EDA2A321-5BDA-4285-847F-16B287896518Q37262700-021FB1F2-A3B2-434A-866C-727875EF8A35Q38133807-7A233763-2B7A-4D98-85FA-C6038FEEC1A0Q38135858-3446F98E-E14B-4B4F-B22B-731BC9BE2E31Q38294121-336DF1E1-3B25-452A-A93D-2233593C12EBQ38374046-E4DA6080-730D-47F9-BD4E-078763B8B423Q38648556-8C3C5E3D-6FB3-4F00-92D2-1BE541CCAAA0Q38845683-2ADDF6F7-7452-4AF7-98EC-B05B9CF1DBD8Q38974667-FCCED221-A85D-4311-A55D-D5276D2C0739
P2860
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
@en
type
label
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
@en
prefLabel
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
@en
P2093
P1476
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.
@en
P2093
Giovanni Musso
Maurizio Cassader
Roberto Gambino
P304
P356
10.1016/J.PLIPRES.2012.11.002
P577
2012-12-01T00:00:00Z